These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 13573425)

  • 1. [Contribution to the parkinsonian effects of chlorpromazine & reserpine].
    HASKOVEC L
    Cas Lek Cesk; 1958 Jul; 97(30):932-8. PubMed ID: 13573425
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oculogyric crises during successive treatment with reserpine & chlorpromazine].
    FREY B; MAUREL H; SPIELMANN JP
    Ann Med Psychol (Paris); 1957 Mar; 115(3):515-9. PubMed ID: 13411735
    [No Abstract]   [Full Text] [Related]  

  • 3. [Systematic neuroleptic therapy with the appearance of parkinsonian states].
    FLUGEL F
    Encephale; 1956; 45(4):1090-2. PubMed ID: 13384343
    [No Abstract]   [Full Text] [Related]  

  • 4. Fatalities in patients receiving chlorpromazine and reserpine during 1956-1957 at Pilgrim State Hospital.
    ZLOTLOW M; PAGANINI AE
    Am J Psychiatry; 1958 Aug; 115(2):154-6. PubMed ID: 13559513
    [No Abstract]   [Full Text] [Related]  

  • 5. Complications of chlorpromazine and reserpine therapy.
    HUSSAR AE
    GP; 1957 May; 15(5):85-93. PubMed ID: 13414977
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of parkinsonism-like syndromes caused by reserpine & chlorpromazine].
    KNAUF HW
    Nervenarzt; 1958 Nov; 29(11):520-2. PubMed ID: 13622879
    [No Abstract]   [Full Text] [Related]  

  • 7. [Extrapyramidal movement disorders during chlorpromazine and reserpine therapy; clinical and electromyographic studies].
    BOURGUIGNON A; DELAY J; DENIKER P; LEMPERIERE T
    Encephale; 1956; 45(4):1093-8. PubMed ID: 13384344
    [No Abstract]   [Full Text] [Related]  

  • 8. Untoward reactions to tranquilizing drugs.
    WARDELL DW
    Am J Psychiatry; 1957 Feb; 113(8):745. PubMed ID: 13394752
    [No Abstract]   [Full Text] [Related]  

  • 9. Breast changes in the male and female with chlorpromazine or reserpine therapy.
    ROBINSON B
    Med J Aust; 1957 Aug; 44(7):239-41. PubMed ID: 13476931
    [No Abstract]   [Full Text] [Related]  

  • 10. [Extrapyramidal syndrome in chlorpromazine and serpasil therapy; clinical symptomatology and therapeutic role].
    STECK H
    Encephale; 1956; 45(4):1083-9. PubMed ID: 13384342
    [No Abstract]   [Full Text] [Related]  

  • 11. The uses and limitations of the newer drugs in the treatment of nervous conditions.
    KINROSS-WRIGHT V
    Wis Med J; 1956 Oct; 55(10):1073-8. PubMed ID: 13371776
    [No Abstract]   [Full Text] [Related]  

  • 12. [Akinetic-abulic syndrome and its importance in pharmacological-psychiatric research].
    BENTE D; FLUGEL F
    Dtsch Med Wochenschr; 1956 Dec; 81(51):2071-4. PubMed ID: 13397291
    [No Abstract]   [Full Text] [Related]  

  • 13. Allergenicity of tranquilizing drugs.
    BERNSTEIN C; KLOTZ SD
    J Am Med Assoc; 1957 Mar; 163(11):930-3. PubMed ID: 13405750
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neuroleptics and the incidence of embolisms of the pulmonary artery according to the autopsy material].
    Borowicz A; Kostkowski A; Lisińska M; Nowak J
    Neurol Neurochir Psychiatr Pol; 1965; 15(6):901-4. PubMed ID: 5864785
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of the side effect of reserpine and combined reserpine-chlorpromazine treatment.
    BARSA J; GOSLINE E; KLINE NS
    Dis Nerv Syst; 1956 Nov; 17(11):352-8. PubMed ID: 13365522
    [No Abstract]   [Full Text] [Related]  

  • 16. Harmine antagonism of drug-induced extra-pyramidal disturbances.
    Blum B; Weizmann H; Simpson GM; Krasilowsky D; Kulcsar IS; Merskey H
    Psychopharmacologia; 1964 Oct; 6(4):307-10. PubMed ID: 5318866
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of anaphylactic death in the mouse toxicity prevention test for TRIC agents.
    Alexander ER; Fresh JW
    Am J Ophthalmol; 1967 May; 63(5):Suppl:1462-9. PubMed ID: 6025172
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic value of extra-pyramidal symptoms in chlorpromazine & reserpine therapy].
    HAASE HJ
    Encephale; 1958; 47(6):519-32. PubMed ID: 13619545
    [No Abstract]   [Full Text] [Related]  

  • 19. [Contribution to the study of the contractility of the uterus after long-term application of small doses of chlorpromazine and reserpine].
    BARDOS A
    Bratisl Lek Listy; 1962 Dec; 42():643-9. PubMed ID: 13966627
    [No Abstract]   [Full Text] [Related]  

  • 20. [Parkinsonian states appearing during chlorpromazine therapy].
    DE BOUCAUD P; FOURNIAL P
    J Med Bord; 1954 Sep; 131(9):881-6. PubMed ID: 13201893
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.